Cargando…
Preclinical testing of oncolytic adenovirus sensitivity in patient-derived tumor organoids
Patient-derived organoids (PDOs) have shown the potential to reflect patient sensitivity to chemotherapeutic or targeted drugs. Recently, we showed that organoid models can also serve as a platform to screen for selectivity and potency of oncolytic adenoviruses (OAds). In this protocol, we describe...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672098/ https://www.ncbi.nlm.nih.gov/pubmed/34950892 http://dx.doi.org/10.1016/j.xpro.2021.101017 |